Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

13. Stockholders' Equity (Details Narrative)

13. Stockholders' Equity (Details Narrative) - USD ($)	3 Months Ended	4 Months Ended	5 Months Ended	6 Months Ended		8 Months Ended		9 Months Ended	11 Months Ended	12 Months Ended
13. Stockholders' Equity (Details Narrative) - USD ($)	Jul. 12, 2018	Jul. 31, 2018	Aug. 22, 2017	Oct. 04, 2018	Oct. 03, 2018	Nov. 21, 2018	Dec. 01, 2017	Jan. 02, 2018	Mar. 02, 2018	Mar. 31, 2019	Mar. 31, 2018	Jul. 27, 2017
Common stock outstanding										1,316,335	685,747
Proceeds from sale of stock, net										$ 4,743,000	$ 4,500,000
Issuance of common stock for services, amount										59,000	90,000
Stock-based compensation										1,635,000	2,500,000
Benchmark Company LLC [Member]
Issuance of common stock for services, shares		765
Stock price		$ 19.62
Stock-based compensation										15,000
Actual, Inc. [Member]
Issuance of common stock for services, shares	1,971		343				609	526
Stock price	$ 22.32		$ 49.77				$ 45.18	$ 52.29				$ 60.66
Stock-based compensation										$ 44,000	$ 90,000
Public Offering [Member]
Proceeds from sale of stock, gross						$ 5,530,000
Proceeds from sale of stock, net						$ 4,743,000
Preferred stock converted						8
Common stock issued upon conversion						90,000
Public Offering [Member] \| Dawson James Securities, Inc. [Member]
Payment of stock issuance costs						$ 167,500
Public Offering [Member] \| Benchmark Company LLC [Member]
Payment of stock issuance costs						$ 74,000
Public Offering [Member] \| Common Stock [Member]
Stock issued new, shares issued						507,156
Public Offering [Member] \| Series C Preferred Stock [Member]
Stock issued new, shares issued						10
Public Offering [Member] \| Warrants [Member]
Stock issued new, shares issued						307,188
Public Offering [Member] \| Warrants [Member] \| Dawson James Securities, Inc. [Member]
Stock issued new, shares issued						7,639
Warrants maturity date						Nov. 16, 2023
Warrants exercise price						$ 9.00
Registered Direct Offering [Member]
Stock issued new, shares issued											158,730
Proceeds from sale of stock, gross											$ 5,000,000
Proceeds from sale of stock, net											$ 4,500,000
Registered Direct Offering [Member] \| Warrants [Member] \| Dawson James Securities, Inc. [Member]
Stock issued new, shares issued									4,762
Warrants maturity date									Mar. 01, 2023
Warrants exercise price									$ 39.38
Registered Direct Offering [Member] \| Units [Member] \| Dawson James Securities, Inc. [Member]
Stock issued new, shares issued									46,000
At Market Issuance Sales Agr [Member]
Stock issued new, shares issued				12,556						29,710	25,333
Proceeds from sale of stock, gross										$ 999,000	$ 1,034,000
Proceeds from sale of stock, net										$ 957,000	$ 968,000
Stock price				$ 21.51
At Market Issuance Sales Agr [Member] \| Common Stock [Member]
Stock issued new, shares issued				12,556	29,710
Proceeds from sale of stock, net				$ 262,000	$ 957,000